Skip to main content
MiiS logo

MiiS — Investor Relations & Filings

Ticker · 6796 ISIN · TW0006796006 TW Manufacturing
Open in API
Filings indexed 19 across all filing types
Latest filing 2026-04-10 Regulatory Filings
Country TW Taiwan
Listing TW 6796

About MiiS

https://www.miis.com.tw

Medimaging Integrated Solution Inc. (MiiS) specializes in the research, development, and manufacture of smart healthcare solutions, focusing on telemedicine, digital healthcare, and AI-assisted medical imaging. The company leverages core competencies in medical optics, mechanical engineering, and electronic modules to produce high-precision diagnostic tools. Key products include the Horus Scope series, which encompasses digital otoscopes, ophthalmoscopes, and imaging systems for ear, nose, throat (ENT), and oral examinations. Additionally, MiiS develops disposable endoscope systems and miniaturized lens modules designed for clinical safety and efficiency. By integrating artificial intelligence into medical imaging, the company provides advanced diagnostic support to healthcare providers worldwide. MiiS adheres to international quality standards, including ISO 13485, ISO 9001, FDA, and CE certifications, ensuring high-performance solutions for the global medical market.

Recent filings

Filing Released Lang Actions
115年3月營業收入
Regulatory Filings Classification · 10% confidence The document text is clearly an access error message (“PAGE CANNOT BE ACCESSED”) rather than any financial filing or report. It does not contain any content matching the defined categories. By default, such miscellaneous or non‐categorized content is mapped to the Regulatory Filings fallback (RNS).
2026-04-10 Chinese
114年第4季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document is a financial disclosure from the Taiwan Stock Exchange's Market Observation Post System (MOPS). It provides specific financial data regarding a company's investment in an overseas subsidiary for the 4th quarter of the 114th year (Republic of China calendar). Since it contains substantive financial data (investment amounts, equity stakes, and profit/loss figures) for a specific quarterly period rather than just an announcement of a report, it qualifies as an Interim/Quarterly Report (IR). Q4 2025
2026-03-30 Chinese
114年第4季大陸投資
Regulatory Filings Classification · 75% confidence The document is a statutory disclosure from Taiwan’s ‘公開資訊觀測站’ detailing the company’s Mainland China investment holdings, amounts, and related notes. It is not an annual or interim financial report, earnings release, or share issuance notice, nor does it fit any specialized category like M&A, dividends, or governance. This type of standalone regulatory compliance table falls under the miscellaneous “Regulatory Filings” category.
2026-03-30 Chinese
114年度財務比率
Fund Information / Factsheet Classification · 75% confidence The document is a concise, tabular presentation of the company’s key financial ratios over the past three years. It consists of a brief (1–2 page equivalent) summary of core financial metrics rather than a full narrative report, earnings announcement, or regulatory notice. This matches the definition of a factsheet (FS).
2026-03-30 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.